UPDATE 2-FDA delays decision on Human Genome lupus drug

* Human Genome shares fall 4 percent (Adds original action date, requested data submitted, updates share price)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.